Safe and Sound: Balancing Safety with Innovation in American Sunscreens
Currently, Americans have access to 16 sunscreen active ingredients approved by the Food and Drug Administration (FDA) to prevent skin cancer. The last time a new OTC (Over the Counter) sunscreen ingredient was added to the FDA sunscreen monograph was 1999. Meanwhile, Europeans have access to 29 sunscreen active ingredients. In the United States there are currently eight new sunscreen ingredients that are pending FDA review, which have been used in Europe – many for over ten years. These new, and potentially better, active ingredients could allow sunscreens to last longer and provide better full spectrum coverage that could help us reverse trends of increasing melanoma incidence in this country. Unlike in Europe where sunscreens are classified as cosmetics, in the United States the FDA is required to evaluate all active ingredients in sunscreens as OTC drugs. Meaning, that all U.S. sunscreen ingredients must be found generally recognized as safe and effective (GRASE) in the same manner as other OTC medications. The FDA says that this is critical to keeping us safe, but is it possible to balance innovation and safety?
Sunscreen Laws may Hinder Protecting Children from Exposure
With the launch of summer comes conventional discussion around ranking sunscreens, and chatter between the experts to parse what should be considered in choosing the most effective among them. It’s also a key conversation among parents heading into the season with an eye on protecting their children from sun exposure. Yet, something remaining a central concern among those parents is the public policy surrounding use of sunscreen in schools.
Melanoma Prevention: The Latest Advances & Future Directions
During my interview with Susan Swetter, MD, Professor of Dermatology,
Stanford University and VA Palo Alto, at the Melanoma Research Alliance Ninth Annual Scientific Retreat in Washington, DC, I inquired about the Panel Discussion she was part of titled: News from the field: What’s going well and what remains to be done?
Turning the Tide Against Cancer Through Sustained Medical Innovation
Guest Blog Contributors Edward Abrahams, Ph.D., President, Personalized Medicine Coalition Margaret Foti, Ph.D., M.D. (h.c.), Chief Executive Officer, American Association for Cancer Research Marcia A. Kean, M.B.A., Chairman, Feinstein Kean Healthcare We live in extraordinary times.
Partners in Prevention: MRA and The Surgeon General's Call to Action to Prevent Skin Cancer
Two years ago, the Melanoma Research Alliance (MRA) met with Dr. Howard Koh, the Assistant Secretary for Health at the Department of Health and Human Services (HHS), and asked the question that launched a milestone project to elevate melanoma and skin cancer on the agenda for public health: “How can...
Protecting Melanoma Research Progress in the Midst of Budget Upheaval
A diagnosis of metastatic melanoma launches individuals and their families into an intense maze of frightening statistics, clinical trials and uncertain prognosis. Here at the Melanoma Research Alliance (MRA), we are focused on the mission of accelerating the research to bring better options to these patients.
Accelerated Approval Adjuvant Therapy Advocacy Allies Anti-PD-1 ASCO Awareness Biopharma biopsy Board Members BRAF Cancer Capitol Hill Clinical Trials Collaborations Combination Therapies Combination Therapy Congress Corporate Partners Detection Diagnostics Drug Development Events Expanded Access Program FDA Francis Collins Funding Fundraising Genetics Grants Health HHS immune checkpoint inhibitors Immunotherapies Immunotherapy Indoor Tanning ipilimumab Kids Legislation Leveraged Finance Fights Melanoma LFFM Louise Perkins May Medical Research Melanoma Melanoma Awareness Melanoma Awareness Month Melanoma Prevention Melanoma Research Melanoma Story Melanoma Survivors microbiome MRA MRA Researchers News NIH Nonprofits Partnering Partnering For Cures Partnerships PASS Coalition Patient Advocacy Patient Forum Patient Story Patient-Centric Care Patients Pediatric Melanoma Policy Prevention Redheads Research research collaboration research funding research grants Researchers Science Sequestration skin biopsy Skin Cancer Skin Cancer Prevention Skin Checks Social Media Sun Safety Sunburn Sunscreen Sunscreen Innovation Act Surgeon General Surgeon General\'s Call to Action to Prevent Skin Cancer Survivor Story Tanning Tanning Bans Tanning Bed Tanning Bed Ban Tanning Beds targeted therapy Teens Treatment Treatments UPF Clothing Wendy Selig young investigator awards Young People